MedPath

Do Biomarkers Predict Response to a Pediatric Chronic Pain Symptom Management Program?

Not Applicable
Recruiting
Conditions
Irritable Bowel Syndrome
Functional Bowel Disorder
Functional Abdominal Pain Disorders
Functional Abdominal Pain Syndrome
Functional Abdominal Pain
Functional Gastrointestinal Disorders
Interventions
Other: Cognitive Behavioral Therapy
Other: Low FODMAP Diet
Registration Number
NCT03823742
Lead Sponsor
Baylor College of Medicine
Brief Summary

The purpose of this study is find out if we can use simple tests (biomarkers) to tell us if a specific child would benefit most from CBT or from the low FODMAPs diet.

Detailed Description

AIM 1: We will categorize children ages 7-12 yrs. of age with FGIDs (n=250) as to whether they have/do not have one or more of the following abnormal physiologic changes: a) Autonomic Nervous System imbalance as indicated by low heart rate variability; and/or (b) Abnormalities in gut physiology: Impaired gut barrier function (increased permeability); and/or increased abundance of species of Gammaproteobacteria and/or Clostridia; and/or Gut neuroimmune dysfunction (increased fecal chromogranin A and secretogranin 2 concentrations).

AIM 2: Children will be randomized to the two treatments most commonly used in clinical practice: CBT or a low FODMAP diet for a 3-week treatment period. We will compare the response to the treatments in those with/without abnormal physiologic biomarkers at 3 weeks, 3 months, and 6 months.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
250
Inclusion Criteria
  • A child 7-12 years of age with a FGID will be recruited if the medical evaluation reveals no organic reason for the abdominal pain and the child has abdominal pain that meets the definition of a FGID (i.e., IBS, functional abdominal pain) according to the pediatric Rome III criteria (Rome IV will be substituted when validated). Parents and children must speak and understand English because of the psychological assessment and CBT requirements.
Exclusion Criteria
  • Children who have: had past bowel surgery; documented GI disorders (e.g., Crohn's disease); a serious chronic medical condition (e.g., diabetes); weight and/or height < 2 SD for age; chronic conditions with GI symptoms (e.g., cystic fibrosis); autism spectrum disorder, significant developmental delay, psychosis, or a history of bipolar disorder; been treated with antibiotics/probiotics within 2 mo. (because of effects on gut microbiome analysis), and children who for some reason could not be randomized to the low FODMAP diet.Vegetarian; children who are currently on the FODMAP Diet or receiving CBT Children who speak only Spanish are not eligible because the Rome questionnaire and psychological testing are not available in Spanish. Despite this, a large proportion of the children enrolled will be Hispanic.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SEQUENTIAL
Arm && Interventions
GroupInterventionDescription
Cognitive Behavioral TherapyCognitive Behavioral TherapyCognitive Behavioral Therapy
Low FODMAP dietLow FODMAP DietLow FODMAP diet
Primary Outcome Measures
NameTimeMethod
Symptom Improvement3 to 4 weeks

Abdominal pain frequency or severity

Secondary Outcome Measures
NameTimeMethod
Improvement in quality of life6 months

PedsQL or Functional Disability

Symptom Improvement6 months

Abdominal pain frequency or severity

Trial Locations

Locations (2)

Children's Nutrition Research Center

🇺🇸

Houston, Texas, United States

Texas Children's Hospital

🇺🇸

Houston, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath